New England Asset Management’s Calumet Specialty Products CLMT Stock Holding History

New England Asset Management’s Portfolio CLMT Stock Details CLMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-3,000	Closed	-$13K	–	149
2017 Q2	$13K	Sell	3,000 -3,000	-50%	-$12K	﹤0.01%	148
2017 Q1	$23K	Hold	6,000	–	–	﹤0.01%	178
2016 Q4	$24K	Buy	+6,000	New	+$24.5K	﹤0.01%	211

Other funds holding CLMT

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

SCM

Springhouse Capital Management Westport, Connecticut $55.3M AUM 20.84% 1-Year Est. Return

AAA

Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return

SPCM

Sound Point Capital Management New York $28.3M AUM 13.25% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

New England Asset Management's CLMT Position: Q3 2017 in Review

New England Asset Management sold out of Calumet Specialty Products (CLMT) in Q3 2017, closing a stake of 3,000 shares — an estimated $13K sold.

New England Asset Management first reported a position in CLMT in Q4 2016 and held it in 3 quarters. The position peaked at $24K in Q4 2016. 72 funds tracked by Wall St. Rank hold CLMT as of Q3 2017.

New England Asset Management reported no remaining Calumet Specialty Products position as of Q3 2017 after selling out during the quarter.
New England Asset Management sold 3,000 Calumet Specialty Products shares in Q3 2017, an estimated $13K.
New England Asset Management first reported a position in Calumet Specialty Products in Q4 2016 and held it in 3 quarters.
New England Asset Management's Calumet Specialty Products position peaked at $24K in Q4 2016.
72 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q3 2017.

Based on New England Asset Management's 13F filing for Q3 2017, filed 14 Nov 2017.